- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma
Total 3138 results
-
RWTH Aachen UniversityTerminated
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
Roswell Park Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI)TerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
All India Institute of Medical Sciences, New DelhiCompletedRenal Cell Carcinoma | Transitional Cell Carcinoma | AML | Renal CystsIndia
-
Achieve Life SciencesCompletedCarcinoma, Transitional Cell | Ureteral Neoplasms | Urethral Neoplasms | Bladder NeoplasmsUnited States
-
BioNTech US Inc.Bristol-Myers SquibbCompletedMelanoma | Carcinoma, Non-Small-Cell Lung | Lung Cancer | Urinary Bladder Cancer | Skin Cancer | Transitional Cell Carcinoma of the Bladder | Malignant Melanoma | Bladder TumorsUnited States
-
Eli Lilly and CompanyCompletedCarcinoma, Transitional CellUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
LanZhou UniversityCompleted
-
Tampere University HospitalTampere UniversityRecruitingUrothelial CarcinomaFinland, Canada
-
Kyowa Kirin, Inc.TerminatedUrothelial CarcinomaUnited States, Spain
-
Incyte CorporationTerminatedUrothelial CarcinomaUnited States, France, Italy
-
AEterna ZentarisUniversity of Miami; University of Miami Sylvester Comprehensive Cancer Center and other collaboratorsTerminatedUrothelial CarcinomaUnited States
-
National Taiwan University HospitalUnknownUrothelial CarcinomaTaiwan
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); PfizerCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Medical Research CouncilCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerCanada, United Kingdom, Norway, New Zealand, Netherlands, South Africa, Brazil, Finland
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
RenJi HospitalRecruitingAspirin as Adjuvant Therapy in Patients With Surgically Treated High Risk Renal Cell CarcinomaChina
-
IRCCS San RaffaeleRecruiting
-
Second Affiliated Hospital, School of Medicine,...Completed
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterDenmark
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Astellas Pharma US, Inc.; Seagen Inc.RecruitingUrothelial CarcinomaUnited States
-
PfizerMerck KGaA, Darmstadt, GermanyActive, not recruiting
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedUrothelial CarcinomaNetherlands
-
DendreonTerminatedUrothelial CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral... and other conditionsUnited States
-
Lawrence FongNational Cancer Institute (NCI); Genentech, Inc.; The V Foundation; Conquer Cancer... and other collaboratorsCompleted
-
Genta IncorporatedUnknownCarcinoma, Transitional CellUnited States, Italy
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Bladder Carcinoma | Metastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Metastatic Transitional Cell CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial CarcinomaUnited States
-
University of Roma La SapienzaNot yet recruitingNon-muscle-invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional... and other conditionsUnited States
-
Vyriad, Inc.Mayo ClinicCompletedUrothelial CarcinomaUnited States
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
Seagen Inc.Merck Sharp & Dohme LLC; RemeGen Co., Ltd.RecruitingUrothelial CarcinomaUnited States, Canada, Australia, Singapore
-
Seagen Inc.RecruitingUrothelial CarcinomaUnited States, France
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingUrothelial CarcinomaUnited States, Canada, United Kingdom, Japan, Australia, Argentina, Chile, Israel
-
BayerActive, not recruitingUrothelial CarcinomaUnited States, Korea, Republic of, Japan, Germany, Italy, Spain, Austria, France
-
University of OklahomaEMD Serono; Aravive, Inc.Active, not recruitingUrothelial CarcinomaUnited States
-
Hoffmann-La RocheActive, not recruitingUrothelial CarcinomaSpain, United States, Korea, Republic of, Canada, United Kingdom, Czechia, Australia, Belgium, Brazil, China, Estonia, Finland, Greece, Hong Kong, Italy, Poland, Portugal, Slovenia, Mexico, Georgia, Russian Federation, Singapore, Th... and more
-
Basilea PharmaceuticaCompletedUrothelial CarcinomaUnited Kingdom, Korea, Republic of, Italy, Canada, France, Spain, Germany, United States, Hungary, Australia, Poland, Switzerland, Czechia, Austria
-
Eli Lilly and CompanyCompletedUrothelial CarcinomaSpain, United States, Poland, Romania, Taiwan, Ukraine, Netherlands, Mexico, Japan, France, Germany, Belgium, Greece, Russian Federation, Turkey, Canada, Israel, Italy, United Kingdom, Denmark, Korea, Republic of, Australia, Hungary
-
Fox Chase Cancer CenterStand Up To Cancer; Van Andel Research InstituteActive, not recruitingUrothelial CarcinomaUnited States
-
University of Colorado, DenverAmgenWithdrawnUrothelial Carcinoma